Common Contracts
9 similar Registration Rights Agreement contracts by Exicure, Inc., Ziopharm Oncology Inc, Assure Holdings Corp., Yumanity Therapeutics, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 14th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 6, 2024, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchasers identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 27th, 2022 • Exicure, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 26, 2022, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchasers identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of June [ ], 2022, by and among Yumanity Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 13th, 2022 • Exicure, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of May 9, 2022, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchasers identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 19th, 2021 • Assure Holdings Corp. • Surgical & medical instruments & apparatus • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 15, 2021, by and among Assure Holdings Corp., a Nevada corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser” and, collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2020 • Assure Holdings Corp. • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of · __, 2020, by and among Assure Holdings Corp., a Nevada corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser” and, collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 13th, 2019 • Ziopharm Oncology Inc • Pharmaceutical preparations • Massachusetts
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 12, 2019, by and between ZIOPHARM Oncology, Inc., a Delaware corporation (the “Company”), and the purchaser set forth on Schedule 1 hereto (the “Purchaser”), and shall become effective as of the Closing (as defined in the Issuance Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 1st, 2019 • Ziopharm Oncology Inc • Pharmaceutical preparations • Massachusetts
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 26, 2019, by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Issuance Agreement, defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 13th, 2018 • Ziopharm Oncology Inc • Pharmaceutical preparations • Massachusetts
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 11, 2018, by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
